CN1197552C - 应用抗炎剂的制剂 - Google Patents

应用抗炎剂的制剂 Download PDF

Info

Publication number
CN1197552C
CN1197552C CNB008081484A CN00808148A CN1197552C CN 1197552 C CN1197552 C CN 1197552C CN B008081484 A CNB008081484 A CN B008081484A CN 00808148 A CN00808148 A CN 00808148A CN 1197552 C CN1197552 C CN 1197552C
Authority
CN
China
Prior art keywords
purposes
preparation
liposome
infection
chemical compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB008081484A
Other languages
English (en)
Chinese (zh)
Other versions
CN1352551A (zh
Inventor
沃尔夫冈·弗莱舍
卡伦·赖默
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of CN1352551A publication Critical patent/CN1352551A/zh
Application granted granted Critical
Publication of CN1197552C publication Critical patent/CN1197552C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
CNB008081484A 1999-05-27 2000-05-25 应用抗炎剂的制剂 Expired - Fee Related CN1197552C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19924313 1999-05-27
DE19924313.1 1999-05-27

Publications (2)

Publication Number Publication Date
CN1352551A CN1352551A (zh) 2002-06-05
CN1197552C true CN1197552C (zh) 2005-04-20

Family

ID=7909362

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008081484A Expired - Fee Related CN1197552C (zh) 1999-05-27 2000-05-25 应用抗炎剂的制剂

Country Status (20)

Country Link
US (1) US7468194B1 (pt)
EP (2) EP1180018B1 (pt)
JP (1) JP5616565B2 (pt)
KR (1) KR100687781B1 (pt)
CN (1) CN1197552C (pt)
AT (2) ATE340561T1 (pt)
AU (1) AU772314B2 (pt)
BR (1) BR0010983A (pt)
CA (1) CA2368192A1 (pt)
CY (1) CY1105849T1 (pt)
DE (3) DE60018409T2 (pt)
DK (1) DK1502586T3 (pt)
ES (2) ES2274372T3 (pt)
HK (1) HK1046242B (pt)
HU (1) HU229598B1 (pt)
IL (2) IL146133A0 (pt)
MX (1) MXPA01012170A (pt)
PT (1) PT1502586E (pt)
RU (1) RU2264827C2 (pt)
WO (1) WO2000072823A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139231A0 (en) * 1998-05-27 2001-11-25 Euro Celtique Sa Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US20030219465A1 (en) * 2002-05-23 2003-11-27 Suresh Kumar Gidwani Composition for delivery of dithranol
DE60315955T2 (de) 2003-05-19 2008-06-05 Euro-Celtique S.A. Trockene liposomale PVP-Jod Zubereitungen
DE102005063375A1 (de) * 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
US8906966B2 (en) 2006-07-13 2014-12-09 Paul Sherwood Medicaments containing panthenol
EP2178526A1 (en) * 2007-07-13 2010-04-28 Prototype Bioforum Limited Injectable pharmaceutical compositions containing panthenol
CN101987109B (zh) * 2009-08-05 2012-07-04 天津金耀集团有限公司 含有聚维酮碘与环糊精包合糖皮质激素的眼用组合物
CN102429862B (zh) * 2011-11-29 2013-05-01 江苏德达医药科技有限公司 一种聚维酮碘眼用缓释滴眼液
CN103143053A (zh) * 2013-03-24 2013-06-12 山东康力医疗器械科技有限公司 新型聚维酮碘抗菌水胶体敷料及其制备方法
CN104147610A (zh) * 2014-06-26 2014-11-19 中国人民解放军第三○九医院 一种附载抗菌成分的高分子微纳米粒及其制备方法
CN106307543B (zh) * 2016-08-22 2020-02-07 青岛农业大学 一种麝香草酚纳米脂质体及其制备方法
CN109180600A (zh) * 2018-09-21 2019-01-11 五邑大学 一种麝香草酚类似物及其应用
CN111329824A (zh) * 2020-04-02 2020-06-26 东元科技有限公司 一种杀菌能力强的洗手消毒剂
US11590056B2 (en) * 2020-07-30 2023-02-28 Sartorius Stedim North America Freeze/thaw containment system for flexible pouch filled with biopharmaceutical fluid, and method of assembling a freeze/thaw containment system, using a protecting body

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615889A (pt) 1952-04-15 1900-01-01
US4113857A (en) 1977-05-16 1978-09-12 The Purdue Frederick Company Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same
US4675009A (en) 1977-11-07 1987-06-23 Lec Tec Corporation Drug dispensing device for transdermal delivery of medicaments
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2536278A1 (fr) 1982-11-18 1984-05-25 Dupont Michele Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies
US4523589A (en) * 1983-06-29 1985-06-18 Krauser Robert S Method and apparatus for treating ailments
FR2591105B1 (fr) 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
SE8603812D0 (sv) 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5049388A (en) 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
IE63869B1 (en) * 1986-11-06 1995-06-14 Res Dev Foundation Aerosols containing liposomes and method for their preparation
JPH0761940B2 (ja) 1986-11-17 1995-07-05 株式会社資生堂 外皮用リポソ−ム製剤
CH672733A5 (pt) 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
US4938965A (en) 1987-07-22 1990-07-03 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Ocular delivery of prophylactic agents
US5246708A (en) 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
CA1303503C (en) 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
ZA892928B (en) * 1988-04-25 1991-01-30 Pro Neuron Inc Pharmaceutical compositions containing deoxyribonucleosides for wound healing
DE3826946C1 (pt) 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US4906476A (en) 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
JPH02204413A (ja) 1989-02-02 1990-08-14 Nonogawa Shoji:Kk 抗真菌外用製剤
JPH04505319A (ja) 1989-04-04 1992-09-17 アルコン　ラボラトリーズ　インコーポレイテッド 創傷、切傷および擦傷に対する治療剤のデリバリーとしてのリポソームの使用
US5232692A (en) 1989-04-28 1993-08-03 Research And Education Institute, Inc. Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
ES2060040T5 (es) 1989-05-31 1999-09-16 Fisons Plc Dispositivo y formulacion de inhalacion de medicamento.
RU2123338C1 (ru) * 1990-06-15 1998-12-20 Сайтел Корпорейшн Фармацевтическая композиция на основе медиатора межклеточной адгезии (варианты), способ ингибирования межклеточной адгезии, способ лечения воспалительного заболевания, способ анализа тестируемого соединения на способность ингибировать клеточную адгезию, способ получения соединения
US5128139A (en) 1991-02-15 1992-07-07 Nu Skin International, Inc. Composition containing liposome-entrapped grapefruit seed extract and method for making
DE4111982C2 (de) 1991-04-12 1998-12-24 Merz & Co Gmbh & Co Stabile kleinpartikuläre Liposomenzubereitungen, deren Herstellung und Verwendung
AU1537292A (en) 1991-04-16 1992-11-17 Nippon Shinyaku Co. Ltd. Method of manufacturing solid dispersion
ATE221379T1 (de) 1991-05-01 2002-08-15 Jackson H M Found Military Med Verfahren zur behandlung infektiöser respiratorischer erkrankungen
WO1993024165A1 (de) 1992-05-29 1993-12-09 Ggu Gesellschaft Für Gesundheits- Und Umweltforschung Mbh & Co. Vertriebs Kg Vorrichtung zur erzeugung inhalierbarer wirkstoffpartikel
CA2097163C (en) * 1992-06-01 2002-07-30 Marianna Foldvari Topical patch for liposomal drug delivery system
AU4066693A (en) 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
US5552158A (en) 1993-02-23 1996-09-03 Norac Technologies Inc. Skin care composition
DE4306475A1 (de) 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
US5270307A (en) 1993-03-26 1993-12-14 The Dow Chemical Company Pyrrolo(1,2-b)-(1,2)-benzothiazin-10-one and its use as an antimicrobial
DE9312509U1 (de) 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
NZ296098A (en) 1994-11-04 2001-05-25 Polymun Scient Immunbio Forsch Super oxide dismutase in liposome and it's use in therapy
US6103706A (en) * 1997-04-29 2000-08-15 New York Blood Center, Inc. Methods for treating viral infections
US20010055610A1 (en) 1997-06-06 2001-12-27 Shunji Nagata Medicament administration system
IL139231A0 (en) 1998-05-27 2001-11-25 Euro Celtique Sa Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract

Also Published As

Publication number Publication date
CA2368192A1 (en) 2000-12-07
DE60018409T2 (de) 2005-12-29
MXPA01012170A (es) 2002-06-21
JP2003500436A (ja) 2003-01-07
AU772314B2 (en) 2004-04-22
EP1502586B1 (en) 2006-09-27
RU2264827C2 (ru) 2005-11-27
IL146133A (en) 2006-12-31
WO2000072823A8 (en) 2001-06-07
ATE340561T1 (de) 2006-10-15
DE60018409D1 (de) 2005-04-07
RU2001135842A (ru) 2003-08-20
DE60031016D1 (de) 2006-11-09
HUP0201038A2 (en) 2002-09-28
BR0010983A (pt) 2002-03-05
CN1352551A (zh) 2002-06-05
JP5616565B2 (ja) 2014-10-29
HK1046242B (zh) 2005-08-12
EP1180018B1 (en) 2005-03-02
EP1180018A1 (en) 2002-02-20
KR20020012234A (ko) 2002-02-15
US7468194B1 (en) 2008-12-23
ATE289805T1 (de) 2005-03-15
CY1105849T1 (el) 2011-02-02
DK1502586T3 (da) 2007-02-05
ES2274372T3 (es) 2007-05-16
HU229598B1 (en) 2014-02-28
DE20022718U1 (de) 2002-04-04
HUP0201038A3 (en) 2003-04-28
DE60031016T2 (de) 2007-05-16
WO2000072823A1 (en) 2000-12-07
HK1046242A1 (en) 2003-01-03
PT1502586E (pt) 2007-01-31
AU5216600A (en) 2000-12-18
IL146133A0 (en) 2002-07-25
EP1502586A1 (en) 2005-02-02
ES2235891T3 (es) 2005-07-16
KR100687781B1 (ko) 2007-02-28
HK1073252A1 (en) 2005-09-30

Similar Documents

Publication Publication Date Title
KR100613706B1 (ko) 항염증용 제제, 특히 귀 및/또는 상부호흡기의 창상치료촉진용 약제 및/또는 소독 약제
CN1352551A (zh) 应用抗炎剂的制剂
US7364749B1 (en) Preparations for the application of anti-infective and/or anti-inflammatory agents
HK1073252B (en) Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention or treatment of inflammations in the interior of the human body

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050420

Termination date: 20190525

CF01 Termination of patent right due to non-payment of annual fee